Arthur Pharmaceuticals is a high-tech innovative pharmaceutical manufacturer, focusing on the development, production and sales of high-end drugs, and is committed to developing high-end generic drugs with global leading advantages. It can develop various dosage forms such as tablets, capsules, injections, and semi-solids. Through CMO cooperation, it has multiple production plants in North America and Asia, and has a wide range of partners in Asia, the United States, and Europe. Recently, Arthur Pharmaceuticals has obtained tens of millions of yuan in A+ round financing. This round of financing was jointly completed by Jiuzhi Capital and Changxing Economic and Technological Development Zone. The funds will be mainly used for the construction of solid preparation production lines and business integration in the United States.
This article is transferred from: https://www.itjuzi.com/investevent/13795462
This site is only for collection, and the copyright belongs to the original author.